Maxceed Capital Group, established in 2018, is a multi-family office style private fund focusing on biotech/medical (eye, infertility, medical devices), automotive (battery, EV), and fintech (cybersecurity, fraud prevention). Typical check size is $1.5M USD, fund size $36M USD. Limited partners are from Taiwan, China, Hong Kong, India, and Singapore, including second- and third-generation industrial and financial groups. Maxceed provides robust industry connections, capital, experience, and corporate strategy support.